Illumina Inc (ILMN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Illumina Inc (ILMN) has a cash flow conversion efficiency ratio of 0.104x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($321.00 Million) by net assets ($3.08 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ILMN equity financing ratio to measure how much of total assets are equity-financed.
Illumina Inc - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Illumina Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Illumina Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Illumina Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Illumina Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dollar Tree Inc
NASDAQ:DLTR
|
0.328x |
|
Inspur Electronic Info Industr
SHE:000977
|
-0.327x |
|
Companhia de Saneamento Básico do Estado de São Paulo - SABESP
F:SAJA
|
0.021x |
|
IHH Healthcare Bhd
KLSE:5225
|
0.029x |
|
TECHTRONIC INDS ADR/5
F:TIB
|
N/A |
|
E.SUN Financial Holding Co Ltd
TW:2884
|
0.056x |
|
Grupo Carso S.A.B. de C.V
MX:GCARSOA1
|
-0.002x |
|
Santos Ltd
AU:STO
|
0.072x |
Annual Cash Flow Conversion Efficiency for Illumina Inc (1999–2025)
The table below shows the annual cash flow conversion efficiency of Illumina Inc from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see ILMN market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.08 Billion | $1.08 Billion | 0.350x | -0.78% |
| 2024-12-31 | $2.37 Billion | $837.00 Million | 0.353x | +323.93% |
| 2023-12-31 | $5.75 Billion | $478.00 Million | 0.083x | +40.07% |
| 2022-12-31 | $6.60 Billion | $392.00 Million | 0.059x | +17.06% |
| 2021-12-31 | $10.74 Billion | $545.00 Million | 0.051x | -77.94% |
| 2020-12-31 | $4.69 Billion | $1.08 Billion | 0.230x | +0.99% |
| 2019-12-31 | $4.61 Billion | $1.05 Billion | 0.228x | -22.07% |
| 2018-12-31 | $3.91 Billion | $1.14 Billion | 0.292x | -0.79% |
| 2017-12-31 | $2.97 Billion | $875.00 Million | 0.295x | -0.76% |
| 2016-12-31 | $2.31 Billion | $687.24 Million | 0.297x | -15.31% |
| 2015-12-31 | $1.88 Billion | $659.60 Million | 0.351x | +2.17% |
| 2014-12-31 | $1.46 Billion | $501.27 Million | 0.343x | +36.17% |
| 2013-12-31 | $1.53 Billion | $386.42 Million | 0.252x | +13.86% |
| 2012-12-31 | $1.32 Billion | $291.87 Million | 0.221x | -33.54% |
| 2011-12-31 | $1.08 Billion | $358.14 Million | 0.333x | +46.36% |
| 2010-12-31 | $1.20 Billion | $272.57 Million | 0.228x | +12.72% |
| 2009-12-31 | $864.25 Million | $174.50 Million | 0.202x | +94.96% |
| 2008-12-31 | $848.60 Million | $87.88 Million | 0.104x | -24.27% |
| 2007-12-31 | $411.68 Million | $56.29 Million | 0.137x | -13.28% |
| 2006-12-31 | $247.34 Million | $39.00 Million | 0.158x | +226.90% |
| 2005-12-31 | $72.50 Million | $-9.01 Million | -0.124x | +54.13% |
| 2004-12-31 | $72.26 Million | $-19.57 Million | -0.271x | +29.69% |
| 2003-12-31 | $47.39 Million | $-18.26 Million | -0.385x | -7.99% |
| 2002-12-31 | $71.74 Million | $-25.59 Million | -0.357x | -248.70% |
| 2001-12-31 | $106.79 Million | $-10.93 Million | -0.102x | +11.29% |
| 2000-12-31 | $124.10 Million | $-14.31 Million | -0.115x | -27.07% |
| 1999-12-31 | $32.03 Million | $-2.91 Million | -0.091x | -- |
About Illumina Inc
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and … Read more